The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.00
Bid: 0.95
Ask: 1.05
Change: 0.00 (0.00%)
Spread: 0.10 (10.526%)
Open: 1.00
High: 1.00
Low: 1.00
Prev. Close: 1.00
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition, Update & Change of Registered Office

12 Jan 2024 16:15

RNS Number : 5915Z
Microsaic Systems plc
12 January 2024
 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a Regulatory Information Service, this information is considered to be in the public domain. Investors who have participated in a market sounding exercise in relation to the Placing will have received additional inside information in relation to the Placing and will be cleansed on that inside information upon announcement of the Placing, at which point additional disclosures will be released to the market, prior to the planned restoration of the Company's New Ordinary Shares to trading on AIM and Admission of the Placing Shares.

 

 

12 January 2024

Microsaic Systems plc

("Microsaic" or the "Company")

 

Acquisition, Update & Change of Registered Office

 

Capitalised terms in this announcement carry the same meaning as in the Circularor subsequent announcements, unless the context indicates otherwise

 

Microsaic Systems plc (AIM: MSYS), the developer of micro-electronic instruments and analytical solutions, announces that its due diligence in connection with the purchase of certain assets of the Modern Water business previously operated by DeepVerge and certain of its subsidiary companies (the "Assets") has now concluded and the Acquisition Agreement has been entered into with DeepVerge. The Company also provides an update below on the expected timing for concluding firm commitments on the Placing, the publication of the Annual Report and Interim Results, Restoration and Admission.

 

Acquisition

 

The Company has today executed and exchanged the Acquisition Agreement with DeepVerge plc and Innovenn UK Limited to acquire certain Assets for a total consideration of £100,000 ("Acquisition"), at completion ("Completion").

 

The Assets comprise the trade and all equipment used by the Modern Water business relating to the manufacturing of the Microtox® bio-reagents, related trade names, intellectual property, design and all manufacturing rights for water testing equipment using Microtox® bio-reagent as a consumable known as the FX, LX and Continuous Toxic Measurement (CTM) machines.

 

Completion is subject to various conditions including admission to trading on AIM ("Admission") of the placing shares to be issued by way of a placing arranged by TPI ("Placing Shares") and the delivery of several intellectual property assignments by no later than 24 January 2024. At Completion the assets will be transferred to the Company and the consideration of £100,000 paid to the sellers.

 

Completion of the Acquisition is expected to become effective by no later than 24 January 2024, following Restoration (the restoration to trading on AIM of the Company's New Ordinary Shares following the Capital Reorganisation) and Admission, both of which are expected on Tuesday 16 January, 2023.

 

A further announcement will be made once Completion of the Acquisition has occurred.

 

Related Party Transaction

 

As previously announced, Dr Nigel Burton, Non-executive Director of the Company, is also a director of DeepVerge and therefore the Acquisition constitutes a related party transaction for the Company pursuant to Rule 13 of the AIM Rules. Bob Moore being the independent director of the Company for the purposes of negotiating and concluding the Acquisition and the requirements of AIM Rule 13, having consulted with Singer Capital Markets Advisory LLP as the Company's nominated adviser, considers the terms of the Acquisition to be fair and reasonable insofar as the Company's shareholders are concerned.

 

Revised Fundraising

 

As previously announced on 4 January 2024, the Company is finalising binding commitments for the Revised Fundraising, being executed by way of the Placing arranged via TPI, and expects to confirm no later than Monday 15 January that it has obtained conditional funding in excess of the revised minimum amount needed for the Acquisition consideration and for the working capital purposes of the enlarged business.

 

Publication of Annual Report & Interim Results

 

Completion of the Revised Fundraising remains conditional upon, inter alia, the publication of both the Annual Report and the Interim Results, in order to be compliant with the requirements of the AIM Rules for Companies in terms of financial reporting. The Company expects to publish the Annual Report & Interims Results after 5.00 p.m. on Monday 15 January, 2024.

 

Restoration and Admission

 

Assuming completion of the above items, inter alia, the Company intends to seek restoration of its New Ordinary Shares to trading on AIM with effect from 7.30 a.m. on Tuesday 16 January, 2024 and has applied for Admission of the Placing Shares to trading on AIM with effect from 8.00 a.m. on Tuesday 16 January 2024.

 

In the event that the Company is unable to proceed with Revised Fundraising or otherwise satisfy any of the necessary prior conditions for Restoration and Admission, then admission of the Company's shares to trading on AIM would be cancelled and a further announcement made in that regard.

 

Change of Registered Office

 

Microsaic Systems plc announces that the registered office of the Company has been changed to 1-5 Park Road, Caterham, Surrey, CR3 5TB.

 

 

Enquiries:

Microsaic Systems plc

Bob Moore, Acting Executive Chairman

+44 (0) 20 3657 0050

via TPI

 

 

Singer Capital Markets(Nominated Adviser & Joint Broker)

Aubrey Powell / Angus Campbell / Oliver Platts

+44 (0)20 7496 3000

 

 

Turner Pope Investments (TPI) Limited(Joint Broker)

Andy Thacker / James Pope

+44 (0) 20 3657 0050

 

About Microsaic Systems

Microsaic has over 20 years' experience in microelectronics and development of instrumentation. The Company has a robust and innovative patent portfolio in cutting-edge technology designed and developed for "Industry 4.0" application serving markets in diversified Industries, Human and Environmental Health. Microsaic's system solutions have enabled analytical detection and characterisation at the point-of-need, whether within a conventional laboratory setting, or within a bioprocessing facility for continuous detection of data at multiple steps in the process workflow.

 

Microsaic's products and solutions are commercially available through global markets via a network of regional and local partners, targeting its core laboratory, manufacturing and point-of-need applications.

 

Indicative Timetable of Principal Events

 

Event

 

Time and/or date ?¹?

Latest date and time by which entry into the conditional Placing commitments needs to announced for the Restoration and Admission to occur as indicated below

Prior to 3.30 p.m. on15 January 2024

Publication of the Report and Accounts and Interim Results, and notification of the same

After 5.00 p.m. on15 January 2024

 

Restoration of New Ordinary Shares to trading on AIM

 

 

7.30 a.m. on16 January 2024

 

Admission of the shares pursuant to the Revised Fundraising to trading on AIM

 

8.00 a.m. on16 January 2024

Completion of the Acquisition

within 5 business days of this announcement

 

Latest date for share certificates overNew Ordinary Shares to be dispatched(where applicable)

 

 

Within 10 days ofRestoration andAdmission

 

Note:

?¹? All of the times referred to in this announcement refer to London time, unless otherwise stated, and are subject to change. In the event that any key item takes longer to occur, Restoration and Admission may move to a later date, in which case a further announcement would be made.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBUGDBCUBDGSD
Date   Source Headline
14th Sep 20163:38 pmRNSGrant of Options
13th Sep 20164:46 pmRNSHolding(s) in Company
13th Sep 201610:45 amRNSHolding(s) in Company
13th Sep 20168:40 amRNSHolding(s) in Company
13th Sep 20168:30 amRNSDirector/PDMR Shareholding
12th Sep 201611:53 amRNSResult of GM, Completion of Placing, TVRs
26th Aug 20164:49 pmRNSResult of Placing
26th Aug 20161:15 pmRNSProposed Placing of New Shares
26th Aug 20161:15 pmRNSHalf-year Report
20th Jun 20163:27 pmRNSAGM Statement
13th Jun 20167:00 amRNSChange of Nominated Adviser and Broker
19th May 20167:00 amRNSDistribution of Annual Report and Accounts
13th May 201612:57 pmRNSAGM Change of Date
16th Mar 20167:00 amRNSAnnual Financial Report
8th Mar 20167:00 amRNSDirectorate Change
24th Feb 20167:00 amRNSTrading Statement
14th Jan 20167:00 amRNSAward of Options
21st Dec 20157:00 amRNSDirectorate Change
2nd Dec 20157:04 amRNSTrading Update & Directorate Change
30th Nov 201511:47 amRNSHolding(s) in Company
23rd Oct 201511:41 amRNSHolding(s) in Company
22nd Oct 20151:12 pmRNSHolding(s) in Company
19th Oct 20151:37 pmRNSResults of EGM and Placing
15th Oct 20157:00 amRNSPlacing - Exercise of Additional Demand Option
13th Oct 20153:30 pmRNSDirector/PDMR Shareholding
30th Sep 20157:44 amRNSPlacing of New Shares
30th Sep 20157:00 amRNSInterim Results
20th May 20157:00 amRNSResult of AGM
8th Apr 20158:34 amRNSNotification of Major Interest in Shares
30th Mar 20157:00 amRNSDistribution of Annual Report and Accounts
23rd Mar 20157:00 amRNSAnnual Financial Report
19th Mar 20157:00 amRNSAppoinment of Chief Operating Officer
16th Mar 20157:00 amRNSOEM Supply Agreement with GE Healthcare
6th Jan 20158:40 amRNSExercise of Share Options
28th Oct 20149:16 amRNSHolding(s) in Company
14th Oct 20142:10 pmRNSHolding(s) in Company
10th Oct 20144:19 pmRNSHolding(s) in Company
10th Oct 20141:15 pmRNSExercise of Share Options
8th Oct 20147:00 amRNSDirectors' Dealings
7th Oct 20147:00 amRNSConditional Placing to Raise £4.4 million
30th Sep 20147:00 amRNSInterim Results
29th Sep 201412:23 pmRNSCommercial Agreement with Gilson Inc.
25th Sep 20147:00 amRNSMicrosaic Systems Signs Commercial Agreement
9th Sep 20147:00 amRNSPlexus chosen as commercial manufacturing partner
15th Jul 201410:06 amRNSDirectorate Change
23rd Jun 20143:08 pmRNSHolding(s) in Company
19th Jun 201412:02 pmRNSHolding(s) in Company
13th Jun 20149:00 amRNSDISTRIBUTION OF ANNUAL REPORT & ACCOUNTS
10th Jun 20149:10 amRNSExercise of share options
3rd Jun 20147:00 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.